Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices
about
Immunotolerant Properties of Mesenchymal Stem Cells: Updated ReviewUse of mesenchymal stem cells for therapy of cardiac diseaseStem cell therapy for chronic ischaemic heart disease and congestive heart failure.An innovative biologic system for photon-powered myocardium in the ischemic heart.Characterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells.The Role of Genetically Modified Mesenchymal Stem Cells in Urinary Bladder Regeneration.Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats.Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.Cell-based therapies for cardiac disease: a cellular therapist's perspective.Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?Potential for Stem Cell-Based Periodontal Therapy.Stem cell therapy for cardiac regeneration: hits and misses.Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.Allogeneic cardiosphere-derived cells for myocardial regeneration: current progress and recent results.Cellular Therapy for Heart Failure.Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Allogeneic mesenchymal precursor cells (MPCs): an innovative approach to treating advanced heart failure.Mechanical Circulatory Support in the Treatment of Advanced Heart Failure.ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesisStem cell therapy for the systemic right ventricle.Mesenchymal stem cells suppress cardiac alternans by activation of PI3K mediated nitroso-redox pathway.Allogeneic cell therapy: a new paradigm in therapeutics.Regulating Stem Cell Secretome Using Injectable Hydrogels with In Situ Network Formation.Allogeneic Precursor Cells for Systolic Heart Failure: A Need for Mechanisms in Humans.Stem Cell Therapy: Healing or Hype? Why Stem Cell Delivery Doesn't Work.Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease.Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells.Emerging Therapies for Congestive Heart Failure.Vascular Development and Regeneration in the Mammalian Heart.A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.Percutaneous Fluoroscopic-Guided Endomyocardial Delivery in an Experimental Model of Left Ventricular Assist Device Support.The Mesenchymal Precursor Cell Marker Antibody STRO-1 Binds to Cell Surface Heat Shock Cognate 70.Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis.SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells.Cell transplantation in heart failure: where do we stand in 2016?
P2860
Q26770107-D836E7FA-8295-47F6-9AD6-276487FD68D2Q27003127-61BCFD85-CA84-46D3-B296-177E737983BDQ30239945-4A9574EF-83E2-47AC-937F-75189E9B7E25Q33797866-399DCA5C-FAFE-41F1-823C-7C62E27D6E66Q35200174-C9BC125A-9613-4826-9DE6-AC52B74F7EB3Q35785287-A331DD09-098F-4F33-BE44-2AA0E364D78EQ35987027-98E6C8FB-9F88-4B23-9475-7900460DDF96Q37624397-06BF30E1-212F-4D93-A977-64B56DF87841Q37698929-6ACD301D-CCC9-41ED-A39A-AA7130241691Q38241994-C4C87562-CB38-4037-9EC1-934E15DD40D2Q38437316-6AABC0DE-3840-4A90-A1F4-69E24B4D6A93Q38522291-2A07EBA8-6580-4FDD-84B8-A7E7BD92D765Q38601272-A27F1A3F-5D7D-4D9F-8358-CD67B41BFE26Q38610604-3C29A96B-F7B2-4EC1-8B95-B4EE5200DEEBQ38676947-9E6C026A-21AB-41A6-B3DB-B11F3028307BQ38859871-978C457C-373B-4518-B62F-9E43A714E5C3Q38874116-D4EB7522-772A-44AE-BB5F-99DB901F405DQ38885298-5698EA87-E936-43F3-914D-849241773584Q39393435-964C2D39-DA68-4744-A024-CC1E34192928Q39471106-8DF46EBE-6E44-4C71-B46B-4E1A2E2192EAQ41233236-9382C58D-DB5F-45CD-97C0-2E3B95753CF7Q41997705-CEAA1396-F023-42FE-BC07-9E1A234486FFQ42353140-56AD95EC-9C18-403E-9EA9-1C882A33BB60Q42545530-1BE2950D-E4AC-4020-B909-42C8411AC97BQ42588105-E6D215BA-5AD5-4C25-A11A-58A6527903B6Q42641725-E1612A1D-16AB-44B2-A1D3-F8D76260F810Q42695888-0DA2454D-0101-44CF-A21F-634699A71DC6Q47136917-63B2DA1F-D465-4210-908B-068B8541980AQ47639049-1F663992-8FF6-4230-812D-0BBF69AEA7D3Q47890976-C9A5EE5B-1150-4583-87A0-3B5BDF72BB1AQ48678269-B76A7B2A-7CC9-4FDA-8E53-69C933665DECQ48742436-E5456347-1DC0-4D5D-948D-34E909802B13Q50212420-C32580CC-50BD-490F-B5CE-76F4501E2167Q51233542-C691954A-2F3E-4CBD-ADB0-BE03206604CAQ52730314-395F9888-7E25-4347-BCD2-9CCB51346EF9Q52731083-05BFB15E-52CA-4A00-86DD-252EB6F1E2BDQ53775191-6B724D0F-5A64-4239-8399-15FF9F1A6F8E
P2860
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mesenchymal precursor cells as ...... eft ventricular assist devices
@ast
Mesenchymal precursor cells as ...... eft ventricular assist devices
@en
Mesenchymal precursor cells as ...... eft ventricular assist devices
@nl
type
label
Mesenchymal precursor cells as ...... eft ventricular assist devices
@ast
Mesenchymal precursor cells as ...... eft ventricular assist devices
@en
Mesenchymal precursor cells as ...... eft ventricular assist devices
@nl
prefLabel
Mesenchymal precursor cells as ...... eft ventricular assist devices
@ast
Mesenchymal precursor cells as ...... eft ventricular assist devices
@en
Mesenchymal precursor cells as ...... eft ventricular assist devices
@nl
P2093
P2860
P1433
P1476
Mesenchymal precursor cells as ...... eft ventricular assist devices
@en
P2093
Anita Szady
Annetine C Gelijns
Benjamin Sun
Carmelo Milano
Charles T Klodell
Daniel Goldstein
David Feldman
Deborah D Ascheim
Donna Skerrett
Doris A Taylor
P2860
P304
P356
10.1161/CIRCULATIONAHA.113.007412
P407
P577
2014-03-28T00:00:00Z